Mesa Laboratories (NASDAQ:MLAB) SVP Brian David Archbold Sells 2,516 Shares of Stock

Mesa Laboratories, Inc. (NASDAQ:MLAB) SVP Brian David Archbold sold 2,516 shares of the business’s stock in a transaction dated Monday, June 22nd. The shares were sold at an average price of $89.50, for a total transaction of $225,182.00. Following the transaction, the senior vice president directly owned 6,377 shares of the company’s stock, valued at $570,741.50. The trade was a 28.29% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Brian David Archbold also recently made the following trade(s):

• On Tuesday, June 16th, Brian David Archbold sold 1,151 shares of Mesa Laboratories stock. The shares were sold at an average price of $101.27, for a total transaction of $116,561.77.

Mesa Laboratories Stock Performance

MLAB opened at $91.97 on Wednesday. The business’s 50 day moving average is $101.87 and its 200-day moving average is $91.09. The stock has a market cap of $507.67 million, a PE ratio of 76.64 and a beta of 0.94. The company has a current ratio of 1.72, a quick ratio of 1.29 and a debt-to-equity ratio of 0.78. Mesa Laboratories, Inc. has a twelve month low of $55.45 and a twelve month high of $113.99.

Mesa Laboratories (NASDAQ:MLAB) last issued its quarterly earnings data on Wednesday, May 27th. The medical instruments supplier reported $1.53 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.78 by ($0.25). Mesa Laboratories had a return on equity of 20.96% and a net margin of 2.69%.The business had revenue of $63.72 million during the quarter, compared to the consensus estimate of $65.21 million. During the same period last year, the company earned ($1.31) earnings per share.

Mesa Laboratories Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, June 15th. Stockholders of record on Friday, May 29th were paid a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date of this dividend was Friday, May 29th. Mesa Laboratories’s payout ratio is currently 53.33%.

Institutional Investors Weigh In On Mesa Laboratories

A number of institutional investors and hedge funds have recently modified their holdings of MLAB. Northwestern Mutual Wealth Management Co. lifted its holdings in shares of Mesa Laboratories by 5,366.7% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 328 shares of the medical instruments supplier’s stock valued at $26,000 after purchasing an additional 322 shares during the last quarter. Caitong International Asset Management Co. Ltd purchased a new position in Mesa Laboratories in the 4th quarter worth about $27,000. Kestra Advisory Services LLC acquired a new stake in Mesa Laboratories during the 4th quarter worth about $55,000. BNP Paribas Financial Markets raised its holdings in Mesa Laboratories by 30.9% during the 3rd quarter. BNP Paribas Financial Markets now owns 1,029 shares of the medical instruments supplier’s stock worth $69,000 after buying an additional 243 shares during the period. Finally, Tower Research Capital LLC TRC lifted its stake in Mesa Laboratories by 432.9% during the second quarter. Tower Research Capital LLC TRC now owns 842 shares of the medical instruments supplier’s stock valued at $79,000 after buying an additional 684 shares in the last quarter. 90.60% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings lowered shares of Mesa Laboratories from a “sell (d+)” rating to a “sell (d)” rating in a research note on Wednesday, June 3rd. Two equities research analysts have rated the stock with a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Reduce” and an average target price of $94.00.

Mesa Laboratories Company Profile

Mesa Laboratories, Inc (NASDAQ: MLAB) is a global provider of instrumentation products designed for critical process monitoring, testing and calibration. Headquartered in Lakewood, Colorado, the company serves a diverse set of end markets including healthcare, pharmaceutical, food and beverage, energy and industrial sectors. With a focus on precision measurement and validation, Mesa Laboratories helps customers ensure regulatory compliance, product safety and operational efficiency across complex manufacturing and sterilization processes.

The company’s product portfolio encompasses biological and chemical indicators for sterilization process validation, digital data loggers and sensors for environmental monitoring, and optical gas analyzers with sample-conditioning solutions for oil, gas and petrochemical applications.